Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline.
Agarwal A, Zeng X, Li S, Rayner D, Foroutan F, Aertgeerts B, Coyac F, Farhoumand PD, Demaine A, Heen AF, Jha V, Machuve E, Nagler E, Tunnicliffe DJ, Guyatt GH, Vandvik PO, Ponte B, Agoritsas T.
Agarwal A, et al. Among authors: aertgeerts b.
BMJ. 2024 Oct 1;387:e080257. doi: 10.1136/bmj-2024-080257.
BMJ. 2024.
PMID: 39353639